-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $145

Benzinga·07/13/2026 12:40:00
语音播报
Guggenheim analyst Vamil Divan maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $140 to $145.